Rapid RV/LV vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI (formerly iSchemaView)
VS
by Powerful Medical

AI Verdict

Rapid RV/LV and PMcardio are both cardiology AI tools, but they focus on different diagnostic modalities and conditions. Rapid RV/LV analyzes CTPA scans to assess pulmonary embolism severity by measuring RV/LV ratios, while PMcardio interprets ECGs to detect over 50 cardiac conditions, including STEMI and reduced LVEF. Therefore, they are not direct competitors but could be complementary in a comprehensive cardiac care pathway.

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary concern is the rapid and accurate assessment of pulmonary embolism (PE) severity through automated right and left ventricle ratio measurements from CTPA scans. This tool is ideal for emergency and critical care settings where quick risk stratification of PE patients with right heart strain is crucial for timely treatment decisions.

View Rapid RV/LV →

Choose PMcardio if…

Choose PMcardio if you need a comprehensive, AI-powered platform for interpreting ECGs to rapidly assess over 50 cardiac conditions, including STEMI/OMI and reduced LVEF. This tool is particularly well-suited for a broad range of healthcare professionals, from paramedics to cardiologists, who require expert-level ECG interpretations at the point of care, especially in emergency situations where accurate and fast diagnoses are critical.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid RV/LV PMcardio
Pricing Contact vendor for pricing information. Freemium
Deployment On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall. Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers deployment via a mobile app and web platform, which generally suggests higher accessibility and ease of use for individual clinicians compared to Rapid RV/LV's on-premises or hybrid deployment. The freemium model also allows users to easily try out the tool.

Clinical Value

PMcardio

PMcardio is clinically validated in over 25 studies and detects over 50 cardiac conditions, including critical ones like STEMI/OMI and reduced LVEF, directly impacting a broader range of clinical decisions at the point of care. Rapid RV/LV focuses on a specific aspect of pulmonary embolism severity.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium pricing model, allowing users to access basic features for free and upgrade for more advanced functionalities. Rapid RV/LV requires contacting the vendor for pricing, which can be a barrier to initial adoption and understanding the total cost of ownership.

Enterprise Readiness

Tie

Both tools demonstrate enterprise readiness. Rapid RV/LV offers on-premises or hybrid deployment with secure integration into hospital networks and HIPAA compliance. PMcardio provides enterprise integrations with EHR/CVIS and EMS systems, also being HIPAA compliant and having a BAA.

Innovation

PMcardio

PMcardio's 'Queen of Hearts' for STEMI/OMI detection, 'LVsense' for reduced LVEF, and 'ECGxplain' for visual AI explainability with heatmaps demonstrate a higher degree of innovative features and a broader application of AI in ECG interpretation. Rapid RV/LV, while valuable, focuses on a more specialized application of AI in CTPA analysis.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details about the level of customer support or documentation available for either Rapid RV/LV or PMcardio. Therefore, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid RV/LV PMcardio
Name Rapid RV/LV PMcardio
Description FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately.
Company RapidAI (formerly iSchemaView) Powerful Medical
Tagline AI-powered rapid assessment of pulmonary embolism severity. AI that reads ECGs in seconds
Primary Data Input CTPA scans ECGs
Key Feature 1 AI-powered analysis of CTPA images Instant AI-powered ECG interpretations
Key Feature 2 Automated measurement of right and left ventricle diameters Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders)

Videos

Demos, reviews, and walkthroughs featuring Rapid RV/LV and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid RV/LV integrates with the broader Rapid PE solution, which includes triage, notification, and workflow products to manage patient care from suspected embolism to treatment. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, allowing it to connect to ECG devices and angiographic systems, be launched from the EHR with secure links and SSO, and send results back to clinical systems for documentation.
Rapid RV/LV uses AI to automatically measure right and left ventricle ratios from CTPA scans, providing critical information for prioritizing pulmonary embolisms and indicating right heart strain. PMcardio, validated in over 25 studies, detects more than 50 cardiac conditions from ECGs. For major ECG abnormalities, PMcardio has shown a sensitivity of 86% and specificity of 92%, and for atrial fibrillation, a sensitivity of 97% and specificity of 99%. Its Queen of Hearts platform for STEMI detection has demonstrated 92% sensitivity and 81% specificity, reducing false-positive cath lab activations.
PMcardio is designed for speed, simplicity, and clinical confidence, aiming to provide instant, AI-powered ECG analysis. PMcardio offers email/help desk support and a help center with tutorials and manuals. There is no specific information available regarding the learning curve or support quality for Rapid RV/LV, but it is part of a broader platform designed to streamline care.
PMcardio for Organizations supports full audit trails, allowing tracking of pathway performance across sites and teams for QA, audits, and protocol optimization. For individuals, the Pro Plan offers a 30-day report history for documentation and audits. Information regarding audit trail features for Rapid RV/LV is not available in the provided facts.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.